Allspring Global Investments Holdings, LLC Geron Corp Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$1.75 - $3.44 $12,183 - $23,949	-6,962 Reduced 1.98%	344,060 $1.14 Million
Q4 2023 Jan 25, 2024	BUY	$1.74 - $2.31 $5,376 - $7,137	3,090 Added 0.89%	351,022 $740,000
Q3 2023 Oct 27, 2023	BUY	$2.11 - $3.28 $734,136 - $1.14 Million	347,932 New	347,932 $737,000
Q2 2023 Jul 18, 2023	SELL	$1.97 - $3.69 $37,132 - $69,552	-18,849 Reduced 6.21%	284,659 $913,000
Q1 2023 Apr 13, 2023	BUY	$2.14 - $3.4 $531,582 - $844,570	248,403 Added 450.78%	303,508 $658,000
Q4 2022 Jan 23, 2023	BUY	$2.03 - $2.42 $34,420 - $41,033	16,956 Added 44.45%	55,105 $0
Q3 2022 Oct 26, 2022	BUY	$1.67 - $2.94 $63,708 - $112,158	38,149 New	38,149 $89,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account